Bio-guided Purification and Mass Spectrometry Characterisation Exploring the Lysozyme-like Protein from Enterococcus lactis Q1, an Unusual Marine Bacterial Strain
Lactic acid bacteria produce various antibacterial peptides such as bacteriocins that are active against pathogenic and spoilage microorganisms. Very little attention has been paid to the production of lysozyme as an antimicrobial enzyme. The present work represents one of the few studies reporting lysozyme production by enterococci. Indeed, this study was first conducted to evaluate the antimicrobial activity of Enterococcus lactis Q1, an enterocin P-producing strain previously isolated from fresh shrimp (Penaeus vannamei), against multidrug-resistant clinical isolates. Results showed significant inhibitory activity (P < 0.05) towards diverse pathogens. The purification of the antimicrobial substances produced by Q1 strain leads to the isolation of two active fractions. The SDS-PAGE and mass spectrometry analyses of fraction number 2 (fraction 2) revealed the presence of a protein with molecular mass of 14.3 kDa. Additionally, the experimental results are consistent with mass spectra of industrial lysozyme (Fluka ref. 62970). The lysozyme produced by Enterococcus lactis Q1 strain was confirmed by a plate method against Micrococcus luteus ATCC 4698. Also, sensitivity of the Q1 strain to different concentrations of lysozyme was investigated. For the first time, this study shows that E. lactis Q1 produces lysozyme which could be an excellent candidate in food biopreservation or production of functional foods to promote health benefits.
KeywordsAntimicrobial activity Enterococcus lactis Lysozyme Mass spectrometry RP-HPLC
This work was supported by a grant from the Ministry of High Education, Tunisia.
Compliance with Ethical Standards
Conflict of Interest
The authors declare that they have no conflict of interest.
- 2.Kovalenko, N. K., & Kasumova, S. A. (1996). The lysozyme-synthesizing activity of enterococci and lactobacilli, Mikrobiolohichnyĭ Zhurnal, 58, 12–8. [In Russian, English abstract].Google Scholar
- 3.Kovalenko, N. K., Nemirovskaia, L. N., & Kasumova, S. A. (1999). The bacteriocinogenic and lysozyme-synthesizing activity of lactobacilli. Mikrobiolohichnyĭ Zhurnal, 61, 42–50. [In Russian, English abstract].Google Scholar
- 14.Jay, J. M. (1966). Production of lysozyme by staphylococci and its correlation with three other extracellular substances. Journal of Biotechnology, 91, 1804–1810.Google Scholar
- 16.Ben Braïek, O., Ghomrassi, H., Cremonesi, P., Morandi, S., Fleury, Y., Le Chevalier, P., Hani, K., Bel Hadj, O., & Ghrairi, T. (2017). Isolation and characterisation of an enterocin P-producing Enterococcus lactis strain from a fresh shrimp (Penaeus vannamei). Antonie Van Leeuwenhoek, 110(6), 771–786.CrossRefGoogle Scholar
- 21.Safaei, H. G., Moghim, S., Isfahani, B. N., Fazeli, H., Poursina, F., Yadegari, S., Nasirmoghadas, P., Abolfazl, S., & Nodoushan, H. (2017). Distribution of the strains of multidrug-resistant, extensively drug-resistant, and pandrug-resistant Pseudomonas aeruginosa isolates from burn patients. Advanced Biomedical Research, 6(1), 74.CrossRefGoogle Scholar
- 27.Hukić, M., Seljmo, D., Ramovic, A., Ibrišimović, M. A., Dogan, S., Hukic, J., & Feric Bojic, E. (2017). The effect of lysozyme on reducing biofilms by Staphylococcus aureus, Pseudomonas aeruginosa, and Gardnerella vaginalis: an in vitro examination. Microbial Drug Resistance. https://doi.org/10.1089/mdr.2013.0303.
- 28.Cintas, L. M., Casaus, P., Havarstein, L. S., Hernandez, P. E., & Nes, I. F. (1997). Biochemical and genetic characterization of enterocin P, a novel sec-dependent bacteriocin from Enterococcus faecium P13 with a broad antimicrobial spectrum. Applied and Environmental Microbiology, 63, 4321–4330.PubMedPubMedCentralGoogle Scholar